Literature DB >> 23089397

Contribution of pulmonary KLRG1(high) and KLRG1(low) CD8 T cells to effector and memory responses during influenza virus infection.

Fang Ye1, Joanne Turner, Emilio Flaño.   

Abstract

In response to pathogen insult, CD8 T cells undergo expansion and a dynamic differentiation process into functionally different subpopulations. In this study, we show that during the effector response to influenza virus infection lung CD8 T cell subsets expressing killer cell lectin-like receptor G1 (KLRG1)(high) or KLRG1(low) had similar effector functions and immediate recall efficacy. The KLRG1 expression profile of lung CD8 T cells was not permanent after adoptive transfer and recall. Airway CD8 T cells exhibited a unique phenotype expressing low levels of KLRG1 together with high levels of markers of cellular activation. We investigated the functional characteristics of these cells by analyzing their capacity to survive and to respond to a secondary challenge outside of the airway environment. KLRG1(high) CD8 T cells isolated from the lung during the peak of the effector T cell response could survive for more than a month in the absence of cognate viral Ags after systemic adoptive transfer, and these "rested" CD8 T cells proliferated and participated in a recall response to influenza virus infection. These data highlight the unique phenotype and plasticity of effector CD8 T cell responses in the lung.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23089397      PMCID: PMC3504136          DOI: 10.4049/jimmunol.1200137

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

1.  Memories of Santa Fe. Symposium on immunologic memory.

Authors:  David L Woodland
Journal:  EMBO Rep       Date:  2007-07-20       Impact factor: 8.807

2.  Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor.

Authors:  Nikhil S Joshi; Weiguo Cui; Anmol Chandele; Heung Kyu Lee; David R Urso; James Hagman; Laurent Gapin; Susan M Kaech
Journal:  Immunity       Date:  2007-08       Impact factor: 31.745

3.  Blimp-1 transcription factor is required for the differentiation of effector CD8(+) T cells and memory responses.

Authors:  Axel Kallies; Annie Xin; Gabrielle T Belz; Stephen L Nutt
Journal:  Immunity       Date:  2009-08-06       Impact factor: 31.745

4.  The NK receptor KLRG1 is dispensable for virus-induced NK and CD8+ T-cell differentiation and function in vivo.

Authors:  Carsten Gründemann; Sabrina Schwartzkopff; Marie Koschella; Oliver Schweier; Christoph Peters; David Voehringer; Hanspeter Pircher
Journal:  Eur J Immunol       Date:  2010-05       Impact factor: 5.532

5.  A role for the transcriptional repressor Blimp-1 in CD8(+) T cell exhaustion during chronic viral infection.

Authors:  Haina Shin; Shawn D Blackburn; Andrew M Intlekofer; Charlly Kao; Jill M Angelosanto; Steven L Reiner; E John Wherry
Journal:  Immunity       Date:  2009-08-06       Impact factor: 31.745

6.  Cutting edge: Virus-specific CD8+ T cell clones and the maintenance of replicative function during a persistent viral infection.

Authors:  Oliver Bannard; Matthew Kraman; Douglas T Fearon
Journal:  J Immunol       Date:  2010-11-10       Impact factor: 5.422

7.  Protective antigen-independent CD8 T cell memory is maintained during {gamma}-herpesvirus persistence.

Authors:  Stephanie S Cush; Emilio Flaño
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

8.  Secondary replicative function of CD8+ T cells that had developed an effector phenotype.

Authors:  Oliver Bannard; Matthew Kraman; Douglas T Fearon
Journal:  Science       Date:  2009-01-23       Impact factor: 47.728

9.  Blimp-1 directly represses Il2 and the Il2 activator Fos, attenuating T cell proliferation and survival.

Authors:  Gislâine A Martins; Luisa Cimmino; Jerry Liao; Erna Magnusdottir; Kathryn Calame
Journal:  J Exp Med       Date:  2008-08-25       Impact factor: 14.307

10.  Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates.

Authors:  Surojit Sarkar; Vandana Kalia; W Nicholas Haining; Bogumila T Konieczny; Shruti Subramaniam; Rafi Ahmed
Journal:  J Exp Med       Date:  2008-03-03       Impact factor: 14.307

View more
  14 in total

1.  Cytomegalovirus vector expressing RAE-1γ induces enhanced anti-tumor capacity of murine CD8+ T cells.

Authors:  Tihana Tršan; Kristina Vuković; Petra Filipović; Ana Lesac Brizić; Niels A W Lemmermann; Kilian Schober; Dirk H Busch; William J Britt; Martin Messerle; Astrid Krmpotić; Stipan Jonjić
Journal:  Eur J Immunol       Date:  2017-07-04       Impact factor: 5.532

2.  Smad4 promotes differentiation of effector and circulating memory CD8 T cells but is dispensable for tissue-resident memory CD8 T cells.

Authors:  Yinghong Hu; Young-Tae Lee; Susan M Kaech; Beth Garvy; Linda S Cauley
Journal:  J Immunol       Date:  2015-01-30       Impact factor: 5.422

3.  Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunity.

Authors:  Daniel O Villarreal; Megan C Wise; Jewell N Walters; Emma L Reuschel; Min Joung Choi; Nyamekye Obeng-Adjei; Jian Yan; Matthew P Morrow; David B Weiner
Journal:  Cancer Res       Date:  2014-01-21       Impact factor: 12.701

Review 4.  Environmental cues orchestrate regional immune surveillance and protection by pulmonary CTLs.

Authors:  Linda S Cauley
Journal:  J Leukoc Biol       Date:  2016-06-17       Impact factor: 4.962

5.  KLRG+ invariant natural killer T cells are long-lived effectors.

Authors:  Kanako Shimizu; Yusuke Sato; Jun Shinga; Takashi Watanabe; Takaho Endo; Miki Asakura; Satoru Yamasaki; Kazuyoshi Kawahara; Yuki Kinjo; Hiroshi Kitamura; Hiroshi Watarai; Yasuyuki Ishii; Moriya Tsuji; Masaru Taniguchi; Osamu Ohara; Shin-ichiro Fujii
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-12       Impact factor: 11.205

6.  Molecular adjuvant IL-33 enhances the potency of a DNA vaccine in a lethal challenge model.

Authors:  Daniel O Villarreal; Nikolaos Svoronos; Megan C Wise; Devon J Shedlock; Matthew P Morrow; Jose R Conejo-Garcia; David B Weiner
Journal:  Vaccine       Date:  2015-04-14       Impact factor: 3.641

7.  High viral burden restricts short-lived effector cell number at late times postinfection through increased natural regulatory T cell expansion.

Authors:  Samuel Amoah; Beth C Holbrook; Rama D Yammani; Martha A Alexander-Miller
Journal:  J Immunol       Date:  2013-04-15       Impact factor: 5.422

Review 8.  Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges.

Authors:  Tin Kyaw; Karlheinz Peter; Yi Li; Peter Tipping; Ban-Hock Toh; Alex Bobik
Journal:  Br J Pharmacol       Date:  2017-06-13       Impact factor: 8.739

9.  Early Decision: Effector and Effector Memory T Cell Differentiation in Chronic Infection.

Authors:  Michael M Opata; Robin Stephens
Journal:  Curr Immunol Rev       Date:  2013-08

10.  Transnuclear CD8 T cells specific for the immunodominant epitope Gra6 lower acute-phase Toxoplasma gondii burden.

Authors:  Anna Sanecka; Nagisa Yoshida; Stephanie K Dougan; John Jackson; Nilabh Shastri; Hidde Ploegh; Nicolas Blanchard; Eva-Maria Frickel
Journal:  Immunology       Date:  2016-08-17       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.